Effectiveness of Integrative Chinese–Western Medicine for Chronic Kidney Disease and Diabetes: A Retrospective Cohort Study

医学 肾脏疾病 内科学 疾病 回顾性队列研究 队列 队列研究 共病
作者
Kam Wa Chan,Tak Yee Chow,Kam Yan Yu,Yibin Feng,Lixing Lao,Zhaoxiang Bian,Vivian Taam Wong,Sydney Chi Wai Tang
出处
期刊:The American Journal of Chinese Medicine [World Scientific]
卷期号:50 (02): 371-388 被引量:24
标识
DOI:10.1142/s0192415x2250015x
摘要

Diabetes and chronic kidney disease (CKD) are pandemic, requiring more therapeutic options. This retrospective cohort evaluated the effectiveness, safety profile and prescription pattern of a pilot integrative medicine service program in Hong Kong. Data from 38 patients with diabetes and CKD enrolled to receive 48-week individualized add-on Chinese medicine (CM) were retrieved from the electronically linked hospital database. A 1:1 cohort was generated with patients from the same source and matched by propensity score. The primary outcomes are the change of estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR) analyzed by analysis of covariance and mixed regression model adjusted for baseline eGFR, age, gender, duration of diabetes history, history of hypertension, diabetic retinopathy, and the use of insulin and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker. The rate of adverse events and the change of key biochemical parameters were analyzed. After a median of 51 weeks, patients who received add-on CM had stabilized eGFR (difference in treatment period: 0.74 ml/min/1.73m 2 , 95% CI: –1.01 to 2.50) and UACR (proportional difference in treatment period: 0.95, 95% CI: 0.67 to 1.34). Add-on CM was associated with significantly preserved eGFR (Inter-group difference: 3.19 ml/min/1.73m 2 , 95%CI: 0.32 to 6.06, [Formula: see text] 0.030) compared to standard care. The intergroup ratio of UACR was comparable (0.70, 95% CI: 0.45 to 1.08, [Formula: see text] 0.104). The result is robust in sensitivity analysis with different statistical methods, and there was no interaction with CKD stage and UACR. The rate of serious adverse events (8.1% vs. 18.9%, [Formula: see text] 0.174), moderate to severe hyperkalemia (8.1% vs. 2.7%, [Formula: see text] 0.304) and hypoglycemia (13.5% vs. 5.4%, [Formula: see text] 0.223), and the levels of key biochemical parameters were comparable between groups. The top seven most used CMs contained two classical formulations, namely Liu-wei-di-huang-wan and Si-jun-zi-tang. Individualized add-on CM was associated with significant kidney function preservation and was well tolerated. Further randomized controlled trials using CM prescriptions based on Liu-wei-di-huang-wan and Si-jun-zi-tang are warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
pillowdamon发布了新的文献求助10
刚刚
mix完成签到,获得积分10
1秒前
路明非完成签到,获得积分10
3秒前
rslysywd完成签到,获得积分10
3秒前
4秒前
4秒前
可爱的函函的应助被演九胜采纳,获得10
9秒前
9秒前
shi完成签到,获得积分10
9秒前
shaofeng发布了新的文献求助10
10秒前
红烧肉发布了新的文献求助10
10秒前
王亚奇的应助被wyy采纳,获得20
11秒前
旺旺完成签到,获得积分10
11秒前
yyy2025完成签到,获得积分10
11秒前
12秒前
虚拟的画板完成签到 ,获得积分10
14秒前
端庄的小蝴蝶完成签到,获得积分10
16秒前
慕青的应助被坚强孤容采纳,获得10
18秒前
打打的应助被旺旺采纳,获得10
18秒前
wy.he完成签到,获得积分0
20秒前
如梦如画完成签到,获得积分10
20秒前
Teddy完成签到,获得积分10
20秒前
祁絢完成签到,获得积分10
21秒前
激流勇进wb完成签到 ,获得积分10
24秒前
25秒前
26秒前
天真南松完成签到,获得积分10
28秒前
YUHL完成签到 ,获得积分10
28秒前
简生pro完成签到,获得积分10
28秒前
饭特稀完成签到,获得积分10
29秒前
天天向上的应助被蟹老板采纳,获得10
29秒前
xing_xing的应助被科研通管家采纳,获得20
29秒前
Jasper的应助被科研通管家采纳,获得10
29秒前
29秒前
29秒前
华仔的应助被科研通管家采纳,获得10
29秒前
30秒前
CodeCraft的应助被科研通管家采纳,获得10
30秒前
上官若男的应助被67采纳,获得10
30秒前
在水一方的应助被科研通管家采纳,获得10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186784
求助须知:如何正确求助?哪些是违规求助? 9575092
关于积分的说明 21839541
捐赠科研通 7784418
什么是DOI,文献DOI怎么找? 3434819
关于科研通互助平台的介绍 2559221
邀请新用户注册赠送积分活动 2481682